Journal metric profile

Current Treatment Options in Allergy

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 1.700 2025 metric year
5-Year Impact Factor 1.300 Longer citation window
JCR Quartile Q3 Subject-category quartile
JCR Category Rank 27/39 Recorded category rank

Current Treatment Options in Allergy JCR impact factor overview

This profile summarizes the journal metrics and publication information available in the current directory record.

Page reviewed August 6, 2026

Current Treatment Options in Allergy metric snapshot

Current Treatment Options in Allergy has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is SPRINGERNATURE. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 1.700. The five-year Journal Impact Factor is 1.300, giving a second citation window for comparison. The journal is recorded in quartile Q3 for its listed JCR category.

Category position and quartile

The recorded JCR category position is 27 out of 39 journals. Based on that rank position, the journal sits within approximately the top 69% of the listed category. Its listed quartile is Q3. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.

How the citation indicators compare

The five-year Journal Impact Factor (1.300) is 0.400 points lower than the standard Journal Impact Factor (1.700). The Impact Factor without journal self-citations is the same as the listed standard value at the displayed precision. The Journal Citation Indicator (JCI) is recorded as 0.430. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.

Citation and publication counts

For 2025, the directory record for Current Treatment Options in Allergy lists total cites: 299; total articles: 0; citable items: 20. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.

Citation half-life profile

The cited half-life is 4.1 years, indicating the median age of items that contributed citations to the journal in the reporting framework. The citing half-life is 6.9 years, indicating the median age of references used by the journal’s articles.

Identifiers and verification

Current Treatment Options in Allergy is identified in this directory by electronic ISSN 2196-3053. The publisher is recorded as SPRINGERNATURE. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.

Complete journal information

Use this table to verify the individual metric values, identifiers and publication details stored for this journal.

Journal nameCurrent Treatment Options in Allergy
Abbreviated journalCURR TREAT OPTION AL
PublisherSPRINGERNATURE
Metric year2025
Overall rank9,720
ISSNNot available
eISSN2196-3053
Total cites299
Total articles0
Citable items20
Cited half-life4.1 years
Citing half-life6.9 years
JCR-based Journal Impact Factor1.700
5-Year Impact Factor1.300
Impact Factor without journal self-cites1.700
Journal Citation Indicator0.430
JCR Impact Factor quartileQ3
JCR category rank27/39
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of Current Treatment Options in Allergy?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for Current Treatment Options in Allergy is 1.700 for the 2025 metric year.

What are the JCR quartile and category rank of Current Treatment Options in Allergy?

Current Treatment Options in Allergy is listed with quartile Q3 and category rank 27/39. These values are category-specific and should be verified against the official JCR record when used for formal assessment.

What is the five-year Journal Impact Factor of Current Treatment Options in Allergy?

The five-year Journal Impact Factor recorded for Current Treatment Options in Allergy is 1.300. It uses a longer citation window than the standard Journal Impact Factor.

Who publishes Current Treatment Options in Allergy?

Current Treatment Options in Allergy is listed in this directory as being published by SPRINGERNATURE.

Additional records from the same publisher or with a similar listed JCR Impact Factor.